• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.27% Nasdaq Up 2.45%

    Insmed Incorporated (INSM)

    -NasdaqGS
    25.13 Up 0.92(3.80%) Aug 27, 4:00PM EDT
    Add to Portfolio
    Prev Close:24.21
    Open:24.45
    Bid:23.96 x 1000
    Ask:N/A
    1y Target Est:34.00
    Beta:-1.04981
    Earnings Date:Nov 4 - Nov 9 (Est.)
    Day's Range:24.21 - 25.20
    52wk Range:12.17 - 28.66
    Volume:487,206
    Avg Vol (3m):403,145
    Market Cap:1.55B
    P/E (ttm):N/A
    EPS (ttm):-1.91
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    INSMUp 3.80%1.55B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.94
    Quarterly EPS Est (Sep-15) :-0.47
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing inhaled therapies for patients with serious lung diseases. Its lead product candidate is ARIKAYCE, an inhaled antibiotic treatment that delivers an anti-in... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback